key: cord-0727792-v7wxnjzf
authors: Garrick, Michael D.; Ghio, Andrew J.
title: Iron chelation may harm patients with COVID-19
date: 2020-09-01
journal: Eur J Clin Pharmacol
DOI: 10.1007/s00228-020-02987-w
sha: 46540398fb68fb824d8bf7adc54b828885a1e258
doc_id: 727792
cord_uid: v7wxnjzf

nan

nutrient required by the microbe for survival and replication. The host's sequestration of its own iron is a critical part of innate immunity. Accordingly, AI following infection can explain observations of decreased hemoglobin in COVID-19 patients. Moreover, the coronavirus is an RNA virus with its replication relying on a RNA duplex intermediate. counterproductive and part of the "cytokine storm" that might be exacerbated by Abobaker's proposed use of iron chelation. Docking models employed to explain hemoglobin loss are predictive of binding only and are unnecessary if hypoferremia in response to AI is the real cause. One needs to determine the K d for binding to learn if the viral proteins can actually outcompete hemoglobin ligands that already have high affinity for some of the target regions. Therefore, the proposal that hemoglobin drops due to an interaction with viral proteins may have confused observations on a clinical hemoglobin measurement that reflects red cell numbers after iron withholding with molecular turnover of the globin tetramer within those cells. Elevated serum ferritin in these patients, comparable to the decreased hemoglobin, reflects inflammation associated with infection and this is supported by more frequently elevated acute phase reactants such as Creactive protein [4] . The classical Hippocratic dictum "primum nil nocere," that is "do no harm," implies here that chelation should not be employed until there is evidence that elevated iron levels exist and are relevant. Before moving in that direction, it must be determined whether COVID-19 leads to elevated iron levels or AI. Useful approaches could include a test that distinguishes whether elevated serum ferritin relates to elevated iron or AI [6] and interrogating whether this new RNA virus has any iron-dependencies. Results could lead to hepcidin antagonists as supportive treatment instead of iron chelation.

Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome?

COVID-19:Attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism

The iron cycle and oxidative stress in the lung

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Anemia of inflammation

Serum ferritin iron, a new test, measures human body iron stores unconfounded by inflammation

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Authors' contributions Not applicable.